{
    "nctId": "NCT02816112",
    "briefTitle": "Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia",
    "officialTitle": "A Multi-Centre Study to Compare Granulocyte-colony Stimulating Factors to Antibiotics for Primary Prophylaxis of Taxotere/Cyclophosphamide-Induced Febrile Neutropenia REaCT-TC2",
    "overallStatus": "COMPLETED",
    "conditions": "Early Stage Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 458,
    "primaryOutcomeMeasure": "Febrile neutropenia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed primary breast cancer\n* Planned TC chemotherapy\n* \u226519 years of age\n* Able to provide verbal consent\n\nExclusion Criteria:\n\n* Contraindication to either Ciprofloxacin or G-CSF",
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}